Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL)

BACKGROUND: To evaluate the strategy for detection of prostate cancer (PCa) with low prostate specific antigen (PSA) level (2.5–4.0 ng/mL), prostate biopsy patients with low PSA were assessed. We evaluated the risk of low PSA PCa and the strategy for screening low-PSA patients. METHODS: We retrospec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Korean Med Sci
Main Authors: Chung, Jae Hoon, Yu, Jiwoong, Song, Wan, Kang, Minyong, Sung, Hyun Hwan, Jeon, Hwang Gyun, Jeong, Byong Chang, Seo, Seong IL, Lee, Hyun Moo, Jeon, Seong Soo
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Academy of Medical Sciences 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7590649/
https://ncbi.nlm.nih.gov/pubmed/33107227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2020.35.e342
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados